ASMB Assembly Biosciences, Inc. - Common Stock
$32,87
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 13, 2026
Rango 52S
$20–$40
65% of range
Calificación del Analista
BUY
10 analysts
Precio Objetivo
$50
+52% upside
P/E (TTM)
-59.8
ROE
-5.5%
Margen de Beneficio Neto
-8.5%
ASMB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$32.87
Capitalización Bursátil
$521M
P/E (TTM)
-59.8
BPA (TTM)
$-0.55
Ingresos (TTM)
$72M
Rendimiento div.
—
ROE
-5.5%
Deuda/Capital
—
Rango 52S
$20 – $40
ASMB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$72M
2016-12-31
→
2025-12-31
BPA
$-0.55
2021-12-31
→
2025-12-31
Flujo de caja libre
$-41M
2016-12-31
→
2025-12-31
Márgenes
-8.5%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
ASMB
Mediana de Pares
P/E (TTM)
-59.8
19.6
P/S (TTM) (P/V (TTM))
7.2
6.4
P/B (P/C)
2.5
2.6
Price / FCF (Precio / FCF)
-12.7
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
ASMB
Mediana de Pares
Operating Margin (Margen Operativo)
-16.8%
—
Net Profit Margin (Margen de Beneficio Neto)
-8.5%
-104.2%
ROA
-3.2%
-40.3%
ROE
-5.5%
-42.4%
ROIC
-5.9%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
ASMB
Mediana de Pares
Current Ratio (Ratio corriente)
5.2
5.4
Quick Ratio (Ratio Rápido)
1.2
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
ASMB
Mediana de Pares
Revenue YoY (Ingresos interanuales)
153.5%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
65.8%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
-1.8%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
ASMB
Mediana de Pares
ASMB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
10 analistas
- Compra fuerte 4 40,0%
- Compra 5 50,0%
- Mantener 1 10,0%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
4 analistas · 2026-08-16
Mediana
$47.50
Media
$50.00
← Por Debajo de Todos los Objetivos
$32.87
Mín
$43.00
Máx
$62.00
Objetivo mediano
$47.50
+44,5%
Objetivo medio
$50.00
+52,1%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.71%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 31 de marzo de 2026 | $-0.54 | $-0.58 | 0.04% |
| 31 de diciembre de 2025 | $2.48 | $-0.66 | 3.1% |
| 30 de septiembre de 2025 | $-0.72 | $-0.79 | 0.07% |
| 30 de junio de 2025 | $-1.33 | $-1.39 | 0.06% |
| 31 de marzo de 2025 | $-1.17 | $-1.63 | 0.46% |
| 31 de diciembre de 2024 | $-1.57 | $-2.08 | 0.51% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| EIKN | — | — | — | — | — | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| R&D Expense | $65M | $56M | $49M | $70M | $69M | $107M | $86M | $73M | $44M | $33M | |
| SG&A Expense | $20M | $18M | $23M | $24M | $29M | $37M | $33M | $35M | $17M | $12M | |
| Operating Expenses | $84M | $74M | $72M | $94M | $139M | $144M | $119M | $108M | $61M | · | |
| Operating Income | $-12M | $-45M | $-65M | $-94M | $-133M | $-65M | $-103M | $-93M | $-52M | $-45M | |
| Other Non-op | $6M | $6M | $3M | $1M | $302.0K | $3M | $4M | $3M | $368.0K | $399.0K | |
| Pretax Income | $-6M | $-40M | $-61M | $-93M | $-132M | $-62M | $-98M | $-90M | $-52M | $-45M | |
| Income Tax | $0 | $330.0K | $33.0K | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Net Income | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| EPS (Basic) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| EPS (Diluted) | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 | · | · | · | · | · | |
| Shares (Basic) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| Shares (Diluted) | 11,210,934 | 6,004,560 | 4,577,371 | 4,034,105 | 43,280,383 | · | · | · | · | · | |
| EBITDA | $-12M | $-45M | $-64M | $-94M | $-132M | $-64M | $-102M | $-93M | $-52M | $-45M |
Balance general 25
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $58M | $38M | $20M | $52M | $46M | $59M | $47M | $41M | $82M | $29M | |
| Short-term Investments | · | · | · | · | · | · | · | $177M | $38M | $24M | |
| Receivables | $974.0K | $0 | $43.0K | $944.0K | $336.0K | $1M | $3M | $2M | $2M | $0 | |
| Prepaid Expense | $5M | $3M | $3M | $4M | $7M | $7M | $5M | $2M | $898.0K | $611.2K | |
| Current Assets | $255M | $116M | $134M | $97M | $154M | $224M | $283M | $223M | $123M | $54M | |
| PP&E (Net) | $221.0K | $284.0K | $385.0K | $743.0K | $1M | $2M | $2M | $557.0K | $860.0K | $214.7K | |
| PP&E (Gross) | · | · | $595.0K | $2M | $2M | $3M | $3M | $1M | $1M | $409.3K | |
| Accum. Depreciation | · | · | $210.0K | $2M | $1M | $2M | $1M | $1M | $414.0K | $194.6K | |
| Goodwill | · | · | · | · | · | $13M | $13M | $13M | $13M | $13M | |
| Intangibles | · | · | · | · | · | · | · | · | $29M | $29M | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $889.0K | $2M | $6M | $2M | $3M | $340.0K | · | |
| Total Assets | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Accounts Payable | $1M | $585.0K | $461.0K | $2M | $3M | $5M | $2M | $4M | · | · | |
| Accrued Liabilities | $8M | $7M | $6M | $7M | $7M | $12M | $8M | $10M | $6M | $5M | |
| Current Liabilities | $49M | $48M | $39M | $16M | $16M | $24M | $24M | $18M | $13M | $7M | |
| Capital Leases | $2M | $3M | $1M | $101.0K | $3M | $7M | $9M | $0 | · | · | |
| Deferred Tax | · | · | · | · | · | $3M | $3M | $3M | · | · | |
| Total Liabilities | $51M | $86M | $96M | $19M | $22M | $43M | $67M | $57M | $56M | $18M | |
| Common Stock | $16.0K | $7.0K | $5.0K | $4.0K | $48.0K | $34.0K | $32.0K | $25.0K | $20.0K | $17.2K | |
| Paid-in Capital | · | · | · | · | · | · | · | $553M | $365M | $289M | |
| Retained Earnings | $-832M | $-826M | $-786M | $-725M | $-631M | $-502M | $-439M | $-342M | $-251M | $-208M | |
| AOCI | $-41.0K | $-211.0K | $-81.0K | $-803.0K | $-419.0K | $-270.0K | $-201.0K | $-347.0K | $-392.0K | $-600.8K | |
| Stockholders' Equity | $207M | $33M | $41M | $83M | $169M | $241M | $273M | $211M | $113M | $80M | |
| Liabilities + Equity | $258M | $119M | $137M | $102M | $191M | $283M | $340M | $268M | $169M | $98M | |
| Shares Outstanding | 15,855,329 | 7,457,240 | 5,482,752 | 4,074,552 | 48,120,437 | 34,026,680 | 32,558,307 | 25,495,425 | 20,137,974 | 17,246,754 |
Flujo de Efectivo 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $129.0K | $129.0K | $450.0K | $498.0K | $466.0K | $691.0K | $494.0K | $643.0K | $219.0K | · | |
| Stock-based Comp | $5M | $3M | $5M | $7M | $5M | $22M | $21M | $28M | $9M | $5M | |
| Deferred Tax | · | $0 | $0 | $0 | $-3M | $0 | $-774.0K | $1M | $-9M | $-618.0K | |
| Restructuring | · | · | $0 | $1M | $2M | $4M | $2M | · | · | · | |
| Other Non-cash | $-40M | $-14M | $78M | $2M | $33M | $-23M | $-7M | · | · | · | |
| Operating Cash Flow | $-41M | $-51M | $23M | $-84M | $-93M | $-63M | $-84M | $-65M | $2M | $-35M | |
| CapEx | $66.0K | $28.0K | $255.0K | $102.0K | $3M | $470.0K | $2M | $340.0K | $865.0K | $147.0K | |
| Investing Cash Flow | $-113M | $40M | $-69M | $91M | $27M | $68M | $-50M | $-135M | $-16M | $36M | |
| Stock Issued | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | $155M | $65M | · | |
| Net Stock Activity | $2M | $2M | $5M | $325.0K | $53M | $5M | $135M | · | · | · | |
| Financing Cash Flow | $175M | $29M | $14M | $614.0K | $53M | $8M | $140M | $160M | $67M | $153.0K | |
| Net Change in Cash | $20M | $19M | $-33M | $7M | $-14M | $13M | $5M | $-41M | $53M | $1M | |
| Taxes Paid | · | $400.0K | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-41M | $-51M | $22M | $-85M | $-96M | $-63M | $-86M | $-65M | $995.5K | $-35M |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -16.8% | -159.3% | -902.5% | · | -2121.7% | -81.9% | -643.4% | -626.4% | · | · | |
| Net Margin | -8.5% | -140.9% | -854.8% | · | -2076.3% | -78.6% | -611.6% | -613.0% | · | · | |
| Pretax Margin | -8.5% | -139.7% | -854.3% | · | -2116.8% | -78.6% | -616.5% | -605.6% | · | · | |
| EBITDA Margin | -16.6% | -158.8% | -896.2% | · | -2114.2% | -81.0% | -640.4% | -626.4% | · | · | |
| ROA | -3.2% | -31.4% | -51.3% | -63.6% | -54.8% | -20.0% | -32.1% | -41.5% | -32.0% | -38.2% | |
| ROE | -5.5% | -135.4% | -147.9% | -100.6% | -66.0% | -24.3% | -45.4% | -41.2% | -44.4% | -44.6% | |
| ROIC | -5.9% | -137.3% | -157.4% | -113.9% | -77.0% | · | -37.3% | -44.6% | -38.1% | -55.9% |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 | 9.2 | 11.6 | 12.0 | 9.1 | 7.5 | |
| Quick Ratio | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 | 2.5 | 2.1 | 11.9 | 9.1 | 7.4 |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.2 | 0.1 | · | 0.0 | 0.3 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | 148.5 | 1326.5 | 14.5 | · | 8.0 | 34.4 | 5.5 | 6.3 | · | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 153.5% | 298.2% | · | · | -92.1% | · | · | · | · | · | |
| Revenue CAGR 3Y | · | 65.8% | -55.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $72M | $29M | $7M | $0 | $6M | $79M | $16M | $15M | $9M | $0 | |
| Net Income TTM | $-6M | $-40M | $-61M | $-93M | $-130M | $-62M | $-98M | $-91M | $-43M | $-44M | |
| Market Cap | $539M | $118M | $54M | $763M | $1.35B | $2.47B | $7.99B | $6.92B | $10.93B | $2.51B | |
| P/E | -61.8 | -2.4 | -0.7 | -0.7 | -9.3 | -41.0 | -68.2 | · | · | · | |
| P/S | 7.5 | 4.1 | 7.5 | · | 215.1 | 31.2 | 500.8 | 467.5 | 1212.4 | · | |
| P/B | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.3 | 29.3 | 32.9 | 96.7 | 31.5 | |
| P / Tangible Book | 2.6 | 3.5 | 1.3 | 9.2 | 8.0 | 10.8 | · | · | · | · | |
| P / Cash Flow | -13.1 | -2.3 | 2.4 | -9.0 | -14.4 | -39.2 | -95.1 | -106.5 | 5878.7 | -72.1 | |
| P / FCF | -13.1 | -2.3 | 2.4 | -9.0 | -13.9 | -38.9 | -93.4 | -106.0 | 10984.2 | -71.8 | |
| Earnings Yield | -1.6% | -42.4% | -136.0% | -148.0% | -10.7% | -2.4% | -1.5% | · | · | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13M | $8M | $42M | $11M | $10M | $9M | $7M | $7M | $9M | $6M | $7M | $0 | $0 | $0 | · | · | |
| R&D Expense | $15M | $15M | $17M | $17M | $16M | $15M | $14M | $14M | $16M | $12M | $11M | $11M | $13M | $15M | $17M | $18M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $4M | $5M | $9M | $4M | $5M | $5M | $6M | $5M | |
| Operating Expenses | $20M | $20M | $23M | $22M | $21M | $19M | $19M | $18M | $21M | $17M | $20M | $15M | $17M | $20M | $23M | $23M | |
| Operating Income | $-6M | $-11M | $20M | $-11M | $-11M | $-10M | $-12M | $-11M | $-12M | $-11M | $-13M | $-15M | $-17M | $-20M | $-23M | $-23M | |
| Other Non-op | $2M | $2M | $2M | $2M | $895.0K | $1M | $1M | $1M | $1M | $2M | $2M | $628.0K | $592.0K | $609.0K | $583.0K | $256.0K | |
| Pretax Income | · | · | $22M | $-9M | $-10M | · | $-10M | $-10M | $-11M | · | $-11M | $-14M | $-17M | · | · | · | |
| Income Tax | · | · | $0 | $0 | $0 | · | $-76.0K | $0 | $406.0K | · | $33.0K | $0 | $0 | · | · | · | |
| Net Income | $-4M | $-9M | $22M | $-9M | $-10M | $-9M | $-10M | $-10M | $-11M | $-9M | $-11M | $-14M | $-17M | $-19M | $-22M | $-23M | |
| EPS (Basic) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| EPS (Diluted) | $-0.20 | $-0.54 | $2.67 | $-0.72 | $-1.33 | $-1.17 | $-1.54 | $-1.51 | $-1.98 | $-1.66 | $-1.75 | $-3.29 | $-3.88 | $-4.46 | $-21.61 | $-0.48 | |
| Shares (Basic) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| Shares (Diluted) | 18,853,646 | 16,900,232 | -16,637,363 | 12,686,122 | 7,655,854 | 7,506,321 | -11,472,936 | 6,351,431 | 5,642,752 | 5,483,313 | -8,409,117 | 4,380,444 | 4,355,007 | 4,251,037 | -140,831,719 | 48,448,399 | |
| EBITDA | $-6M | $-11M | · | $-11M | $-11M | $-10M | · | $-11M | $-12M | $-11M | · | $-15M | $-17M | $-19M | · | $-23M |
Balance general 20
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $31M | $58M | $23M | $24M | $23M | $38M | $28M | $19M | $19M | $20M | $27M | $22M | $43M | $52M | $55M | |
| Receivables | $822.0K | $451.0K | $974.0K | $912.0K | · | · | $0 | $0 | $0 | $43.0K | $43.0K | $0 | $342.0K | $717.0K | $944.0K | $1M | |
| Prepaid Expense | $7M | $6M | $5M | $3M | $2M | $4M | $3M | $3M | $4M | $4M | $3M | $3M | $4M | $6M | $4M | $5M | |
| Current Assets | $328M | $233M | $255M | $237M | $77M | $96M | $116M | $98M | $113M | $117M | $134M | $50M | $64M | $80M | $97M | $115M | |
| PP&E (Net) | $315.0K | $214.0K | $221.0K | $229.0K | $219.0K | $251.0K | $284.0K | $316.0K | $349.0K | $367.0K | $385.0K | $561.0K | $541.0K | $619.0K | $743.0K | $867.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | · | |
| Other Non-current Assets | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $312.0K | $552.0K | $332.0K | $334.0K | $889.0K | $2M | |
| Total Assets | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Accounts Payable | $1M | $1M | $1M | $2M | $743.0K | $875.0K | $585.0K | $1M | $801.0K | $727.0K | $461.0K | $758.0K | $904.0K | $1M | $2M | $2M | |
| Accrued Liabilities | $3M | $3M | $8M | $6M | $3M | $2M | $7M | $5M | $4M | $2M | $6M | $4M | $4M | $3M | $7M | $6M | |
| Current Liabilities | $23M | $35M | $49M | $53M | $47M | $47M | $48M | $42M | $41M | $39M | $39M | $7M | $9M | $10M | $16M | $15M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $113.0K | $451.0K | $791.0K | $1M | $50.0K | $64.0K | $80.0K | $101.0K | $918.0K | |
| Total Liabilities | $25M | $37M | $51M | $57M | $63M | $72M | $86M | $74M | $81M | $87M | $96M | $10M | $12M | $13M | $19M | $19M | |
| Common Stock | $20.0K | $16.0K | $16.0K | $16.0K | $8.0K | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $53.0K | $52.0K | $52.0K | $4.0K | $48.0K | |
| Retained Earnings | $-845M | $-841M | $-832M | $-854M | $-845M | $-835M | $-826M | $-816M | $-806M | $-795M | $-786M | $-775M | $-760M | $-743M | $-725M | $-702M | |
| AOCI | $-623.0K | $-368.0K | $-41.0K | $-90.0K | $-279.0K | $-253.0K | $-211.0K | $-156.0K | $-293.0K | $-239.0K | $-81.0K | $-275.0K | $-325.0K | $-513.0K | $-803.0K | $-999.0K | |
| Stockholders' Equity | $306M | $199M | $207M | $183M | $18M | $27M | $33M | $26M | $35M | $33M | $41M | $42M | $55M | $70M | $83M | $102M | |
| Liabilities + Equity | $331M | $236M | $258M | $240M | $81M | $99M | $119M | $100M | $115M | $120M | $137M | $52M | $67M | $83M | $102M | $122M | |
| Shares Outstanding | 19,850,342 | 15,892,353 | 15,855,329 | 15,816,987 | 7,672,249 | 7,618,885 | 7,457,240 | 6,354,414 | 6,345,561 | 5,482,752 | 5,482,752 | 52,614,194 | 52,450,731 | 52,015,268 | 4,074,552 | 48,481,194 |
Flujo de Efectivo 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $20.0K | $26.0K | $32.0K | $32.0K | $32.0K | $33.0K | $32.0K | $33.0K | $32.0K | $32.0K | $84.0K | $116.0K | $126.0K | $124.0K | $124.0K | $134.0K | |
| Stock-based Comp | $2M | $1M | $1M | $2M | $834.0K | $712.0K | $751.0K | $797.0K | $833.0K | $739.0K | $959.0K | $1M | $1M | $2M | $2M | $2M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-700.0K | $800.0K | |
| Other Non-cash | · | $-14M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-15M | $-22M | $14M | $-15M | $-17M | $-23M | $-407.0K | $-15M | $-17M | $-18M | $74M | $-14M | $-14M | $-23M | $-19M | $-20M | |
| CapEx | $0 | $19.0K | $24.0K | $42.0K | $0 | $0 | $0 | $0 | $14.0K | $14.0K | $71.0K | $136.0K | $48.0K | $0 | $0 | $102.0K | |
| Investing Cash Flow | $-92M | $-5M | $21M | $-158M | $17M | $7M | $-7M | $24M | $5M | $17M | $-90M | $19M | $-8M | $10M | $17M | $31M | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $2M | $2M | $0 | $0 | $0 | $0 | $0 | $54.0K | $4M | $325.0K | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $2M | · | · | · | $0 | · | · | · | $4M | · | · | |
| Financing Cash Flow | $109M | $149.0K | $456.0K | $172M | $357.0K | $2M | $17M | $0 | $12M | $0 | $9M | $0 | $134.0K | $4M | $437.0K | $0 | |
| Net Change in Cash | $1M | $-27M | $36M | $-1M | $593.0K | $-15M | $10M | $9M | $459.0K | $-1M | $-7M | $5M | $-22M | $-9M | $-2M | $12M | |
| Free Cash Flow | · | $-22M | · | · | · | $-23M | · | · | · | $-18M | · | · | · | · | · | · |
Rentabilidad 7
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -47.4% | -138.4% | · | -100.9% | -115.2% | -105.5% | · | -160.1% | -143.0% | -185.5% | · | · | · | · | · | · | |
| Net Margin | -28.8% | -110.5% | · | -85.2% | -105.9% | -93.6% | · | -140.4% | -130.7% | -156.9% | · | · | · | · | · | · | |
| Pretax Margin | · | · | · | -85.2% | -105.9% | · | · | -140.4% | -125.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -47.4% | -138.1% | · | -100.9% | -115.2% | -105.2% | · | -160.1% | -143.0% | -184.9% | · | · | · | · | · | · | |
| ROA | -1.9% | -5.4% | · | -5.4% | -10.4% | -8.1% | · | -12.7% | -12.3% | -8.9% | · | -16.7% | -16.1% | -15.4% | · | -12.5% | |
| ROE | -2.4% | -8.0% | · | -8.8% | -38.6% | -29.5% | · | -28.4% | -24.9% | -17.6% | · | -20.0% | -18.9% | -17.5% | · | -14.1% | |
| ROIC | · | · | · | -6.0% | -61.3% | · | · | -42.1% | -36.5% | · | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.0 | 6.6 | · | 4.4 | 1.6 | 2.0 | · | 2.4 | 2.7 | 3.0 | · | 7.0 | 7.3 | 8.0 | · | 7.4 | |
| Quick Ratio | 1.4 | 0.9 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.5 | 0.5 | · | 3.7 | 2.5 | 4.4 | · | 3.6 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | · | · | |
| Receivables Turnover | 32.5 | 33.3 | · | 23.7 | · | · | · | · | 49.9 | 15.2 | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $42M | $38M | · | $37M | $34M | $31M | · | $21M | $14M | $6M | · | · | · | · | · | · | |
| Net Income TTM | $-32M | $-37M | · | $-38M | $-40M | $-39M | · | $-44M | $-52M | $-59M | · | $-73M | $-83M | $-90M | · | $-90M | |
| Market Cap | $545M | $441M | · | $405M | $139M | $73M | · | $96M | $87M | $73M | · | $562M | $724M | $524M | · | $954M | |
| P/E | -9.8 | -7.4 | · | -5.4 | -3.0 | -1.5 | · | -1.8 | -1.3 | -1.0 | · | -0.9 | -1.5 | -1.7 | · | -10.5 | |
| P/S | 13.0 | 11.6 | · | 11.0 | 4.0 | 2.4 | · | 4.5 | 6.1 | 12.6 | · | · | · | · | · | · | |
| P/B | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Tangible Book | 1.8 | 2.2 | · | 2.2 | 7.7 | 2.7 | · | 3.7 | 2.5 | 2.2 | · | 13.5 | 13.2 | 7.5 | · | 9.3 | |
| P / Cash Flow | · | -20.0 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | -22.4 | · | · | |
| P / FCF | · | -19.9 | · | · | · | -3.1 | · | · | · | -4.0 | · | · | · | · | · | · | |
| Earnings Yield | -10.2% | -13.6% | · | -18.5% | -33.1% | -66.1% | · | -55.8% | -78.8% | -99.9% | · | -113.4% | -67.6% | -58.8% | · | -9.6% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $72M | $29M | $7M | $0 | $6M |
| Margen Operativo % | -16.8% | -159.3% | -902.5% | — | -2121.7% |
| Beneficio neto | $-6M | $-40M | $-61M | $-93M | $-130M |
| EPS Diluido | $-0.55 | $-6.69 | $-13.38 | $-23.08 | $-3.00 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 5.2 | 2.4 | 3.4 | 6.0 | 9.6 |
| Ratio Rápido | 1.2 | 0.8 | 0.5 | 3.3 | 2.9 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-41M | $-51M | $22M | $-85M | $-96M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 98 declarantes · $481.1M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 40 (+23 vs trimestre anterior) | 13 (+4 vs trimestre anterior) | 29 (0 vs trimestre anterior) | 18 (+4 vs trimestre anterior) | +4.9M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $136 770 406 | 4 977 089 | 28,43% | Acciones |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $44 094 133 | 1 604 590 | 9,17% | Acciones |
| Paradigm Biocapital Advisors LP | $42 696 995 | 1 553 748 | 8,88% | Acciones |
| Commodore Capital LP | $38 884 200 | 1 415 000 | 8,08% | Acciones |
| RA CAPITAL MANAGEMENT, L.P. | $28 040 867 | 1 020 410 | 5,83% | Acciones |
| JANUS HENDERSON GROUP PLC | $23 479 147 | 849 309 | 4,88% | Acciones |
| Parkman Healthcare Partners LLC | $19 818 054 | 721 181 | 4,12% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $15 359 726 | 558 942 | 3,19% | Acciones |
| Point72 Asset Management, L.P. | $12 657 096 | 460 593 | 2,63% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $8 211 216 | 298 807 | 1,71% | Acciones |
| Schonfeld Strategic Advisors LLC | $6 654 363 | 242 153 | 1,38% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $6 595 964 | 239 963 | 1,37% | Acciones |
| AMERIPRISE FINANCIAL INC | $6 320 400 | 230 000 | 1,31% | Acciones |
| DV EQUITIES, LLC | $6 221 884 | 226 415 | 1,29% | Acciones |
| Aberdeen Group plc | $5 689 652 | 207 047 | 1,18% | Acciones |
| Seven Fleet Capital Management LP | $5 680 995 | 206 732 | 1,18% | Acciones |
| Affinity Asset Advisors, LLC | $5 221 200 | 190 000 | 1,09% | Acciones |
| B Group, Inc. | $4 828 401 | 175 706 | 1,00% | Acciones |
| STATE STREET CORP | $4 724 664 | 171 931 | 0,98% | Acciones |
| STEMPOINT CAPITAL LP | $4 681 987 | 170 378 | 0,97% | Acciones |
| Squadron Capital Management LLC | $4 396 800 | 160 000 | 0,91% | Acciones |
| Woodline Partners LP | $4 143 434 | 150 780 | 0,86% | Acciones |
| Driehaus Capital Management LLC | $4 122 000 | 150 000 | 0,86% | Acciones |
| Ally Bridge Group (NY) LLC | $3 847 200 | 140 000 | 0,80% | Acciones |
| GOLDMAN SACHS GROUP INC | $3 359 155 | 122 240 | 0,70% | Acciones |
| FRANKLIN RESOURCES INC | $3 110 736 | 113 200 | 0,65% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 504 884 | 91 153 | 0,52% | Acciones |
| VANGUARD GROUP INC | $2 269 895 | 66 742 | 0,47% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 032 696 | 73 970 | 0,42% | Acciones |
| HighVista Strategies LLC | $2 017 170 | 73 405 | 0,42% | Acciones |
| Qube Research & Technologies Ltd | $1 414 890 | 51 488 | 0,29% | Acciones |
| MONIMUS CAPITAL MANAGEMENT, LP | $1 307 498 | 47 580 | 0,27% | Acciones |
| Trexquant Investment LP | $1 254 764 | 45 661 | 0,26% | Acciones |
| XTX Topco Ltd | $1 179 387 | 42 918 | 0,25% | Acciones |
| JPMORGAN CHASE & CO | $1 126 389 | 41 780 | 0,23% | Acciones |
| MORGAN STANLEY | $1 116 705 | 40 637 | 0,23% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $1 083 839 | 39 441 | 0,23% | Acciones |
| BlackRock, Inc. | $980 926 | 35 696 | 0,20% | Acciones |
| Squarepoint Ops LLC | $940 201 | 34 214 | 0,20% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $800 437 | 29 128 | 0,17% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $665 098 | 24 203 | 0,14% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $653 062 | 23 765 | 0,14% | Acciones |
| Caption Management, LLC | $627 341 | 22 829 | 0,13% | Acciones |
| ADAR1 Capital Management, LLC | $561 884 | 20 447 | 0,12% | Acciones |
| Palumbo Wealth Management LLC | $545 891 | 19 865 | 0,11% | Acciones |
| CITADEL ADVISORS LLC | $508 380 | 18 500 | 0,11% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $502 884 | 18 300 | 0,10% | Opción de venta |
| TWO SIGMA INVESTMENTS, LP | $490 738 | 17 858 | 0,10% | Acciones |
| Engineers Gate Manager LP | $488 210 | 17 766 | 0,10% | Acciones |
| Eversept Partners, LP | $453 695 | 16 510 | 0,09% | Acciones |
| Susquehanna Portfolio Strategies, LLC | $415 745 | 15 129 | 0,09% | Acciones |
| Cubist Systematic Strategies, LLC | $413 716 | 16 161 | 0,09% | Acciones |
| Virtus Investment Advisers, LLC | $391 617 | 14 251 | 0,08% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $363 808 | 13 239 | 0,08% | Acciones |
| RHUMBLINE ADVISERS | $318 486 | 11 590 | 0,07% | Acciones |
| Integrated Quantitative Investments LLC | $276 943 | 10 078 | 0,06% | Acciones |
| CITADEL ADVISORS LLC | $271 942 | 9 896 | 0,06% | Acciones |
| DEUTSCHE BANK AG\ | $264 220 | 9 615 | 0,05% | Acciones |
| BANK OF AMERICA CORP /DE/ | $262 901 | 9 567 | 0,05% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $239 076 | 8 700 | 0,05% | Opción de compra |
| Bank of New York Mellon Corp | $234 075 | 8 518 | 0,05% | Acciones |
| CANADA PENSION PLAN INVESTMENT BOARD | $233 580 | 8 500 | 0,05% | Acciones |
| EntryPoint Capital, LLC | $227 672 | 8 285 | 0,05% | Acciones |
| WELLS FARGO & COMPANY/MN | $226 792 | 8 253 | 0,05% | Acciones |
| Brevan Howard Capital Management LP | $213 382 | 7 765 | 0,04% | Acciones |
| Persistent Asset Partners Ltd | $190 766 | 6 942 | 0,04% | Acciones |
| MetLife Investment Management, LLC | $161 720 | 5 885 | 0,03% | Acciones |
| BARCLAYS PLC | $140 314 | 5 106 | 0,03% | Acciones |
| Vanguard Global Advisers, LLC | $126 820 | 4 615 | 0,03% | Acciones |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $124 182 | 4 519 | 0,03% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $115 416 | 4 200 | 0,02% | Acciones |
| MARSHALL WACE, LLP | $111 184 | 4 046 | 0,02% | Acciones |
| CITIGROUP INC | $109 508 | 3 985 | 0,02% | Acciones |
| Invesco Ltd. | $107 969 | 3 929 | 0,02% | Acciones |
| Nuveen, LLC | $100 824 | 3 669 | 0,02% | Acciones |
| Police & Firemen's Retirement System of New Jersey | $79 884 | 2 907 | 0,02% | Acciones |
| NORTHERN TRUST CORP | $42 512 | 1 547 | 0,01% | Acciones |
| Legal & General Group Plc | $26 326 | 958 | 0,01% | Acciones |
| Ameritas Investment Partners, Inc. | $24 595 | 895 | 0,01% | Acciones |
| Russell Investments Group, Ltd. | $21 654 | 788 | 0,00% | Acciones |
| HSBC HOLDINGS PLC | $17 104 | 16 935 | 0,00% | Acciones |
| Tower Research Capital LLC (TRC) | $14 564 | 530 | 0,00% | Acciones |
| ROYAL BANK OF CANADA | $12 000 | 440 | 0,00% | Acciones |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7 145 | 260 | 0,00% | Acciones |
| Accent Capital Management, LLC | $5 826 | 212 | 0,00% | Acciones |
| Sterling Capital Management LLC | $5 469 | 199 | 0,00% | Acciones |
| Truvestments Capital LLC | $5 304 | 193 | 0,00% | Acciones |
| FMR LLC | $4 891 | 178 | 0,00% | Acciones |
| Integrated Wealth Concepts LLC | $2 968 | 108 | 0,00% | Acciones |
| OSAIC HOLDINGS, INC. | $2 748 | 100 | 0,00% | Acciones |
| Quarry LP | $2 061 | 75 | 0,00% | Acciones |
| Caitong International Asset Management Co., Ltd | $2 061 | 75 | 0,00% | Acciones |
| EverSource Wealth Advisors, LLC | $1 511 | 55 | 0,00% | Acciones |
| GSA CAPITAL PARTNERS LLP | $1 180 | 42 931 | 0,00% | Acciones |
| UBS Group AG | $550 | 20 | 0,00% | Acciones |
| Point72 Europe (London) LLP | $332 | 13 | 0,00% | Acciones |
| Allworth Financial LP | $275 | 10 | 0,00% | Acciones |
| PRICE T ROWE ASSOCIATES INC /MD/ | $226 | 8 203 | 0,00% | Acciones |
Informantes de la empresa 34 insiders · 14 directivos · 16 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Jason A Okazaki | CEO and President | 29 de marzo de 2026 A | 163 354 | 0 | 0 | $0 |
| Samar Michael P. | Chief Financial Officer | 25 de julio de 2022 S | 77 228 | 0 | 0 | $0 |
| Thomas Joseph Russo | CFO | 29 de marzo de 2021 A | 54 633 | 0 | 0 | $0 |
| Graham K Cooper | Chief Financial Officer and Chief Operating Officer | 29 de marzo de 2019 A | 117 500 | 0 | 0 | $0 |
| Jeanette M Bjorkquist | PFO and PAO | 17 de junio de 2026 S | 14 560 | 0 | 3 | $-9 429 |
| Anuj Gaggar | Chief Medical Officer | 29 de marzo de 2026 A | 42 688 | 0 | 0 | $0 |
| Nicole S White | Chief Manufacturing Officer | 29 de marzo de 2026 A | 48 145 | 0 | 2 | $-5 257 |
| William E Delaney IV | Chief Scientific Officer | 29 de marzo de 2026 A | 60 330 | 0 | 0 | $0 |
| Luisa M Stamm | Chief Medical Officer | 29 de marzo de 2022 A | 40 315 | 0 | 0 | $0 |
| Jacqueline Sybil Papkoff | SVP-CSO Microbiome | 14 de diciembre de 2020 S | 37 364 | 0 | 0 | $0 |
| Richard James Colonno | EVP & CSO, Virology Ops | 27 de marzo de 2020 A | 137 009 | 0 | 0 | $0 |
| Uri A Lopatin | Chief Medical Officer | 29 de marzo de 2019 A | 627 361 | 0 | 0 | $0 |
| Thomas E Rollins | Chief Development Officer | 29 de marzo de 2018 A | 3 750 | 0 | 0 | $0 |
| Thomas Andrew Rowland | Chief Business Officer | 15 de enero de 2012 A | — | 0 | 0 | $0 |
| Michael Houghton | Consejero | 4 de junio de 2026 A | 3 202 | 0 | 0 | $0 |
| Lisa Johnson-Pratt | Consejero | 4 de junio de 2026 A | — | 0 | 0 | $0 |
| John G Mchutchison | Consejero | 4 de junio de 2026 A | 18 347 | 0 | 0 | $0 |
| Gina Consylman | Consejero | 4 de junio de 2026 A | — | 0 | 0 | $0 |
| Susan Mahony | Consejero | 4 de junio de 2026 A | — | 0 | 0 | $0 |
| Anthony E Altig | Consejero | 4 de junio de 2026 A | 40 000 | 0 | 0 | $0 |
| William R Ringo | Consejero | 5 de junio de 2025 A | 17 465 | 0 | 0 | $0 |
| Richard D Dimarchi | Consejero | 25 de mayo de 2022 A | — | 0 | 0 | $0 |
| Myron Z Holubiak | Consejero | 20 de mayo de 2021 A | — | 0 | 0 | $0 |
| Helen Kim | Consejero | 11 de junio de 2020 A | — | 0 | 0 | $0 |
| Alan Lewis | Consejero | 11 de junio de 2020 A | — | 0 | 0 | $0 |
| Derek A Small | Consejero | 2 de enero de 2020 A | 828 791 | 0 | 0 | $0 |
| Mark Auerbach | Consejero | 17 de mayo de 2019 A | — | 0 | 0 | $0 |
| Russell H Ellison | Consejero | 10 de julio de 2014 A | 21 600 | 0 | 0 | $0 |
| Joseph Felder | Consejero | 6 de marzo de 2013 A | — | 0 | 0 | $0 |
| Gilead Sciences, Inc. | Propietario del 10% | 8 de agosto de 2025 P | 4 505 391 | 0 | 0 | $0 |
| Alexander Schornstein | Propietario del 10% | 25 de noviembre de 2024 P | 728 113 | 0 | 0 | $0 |
| EcoR1 Capital Fund Qualified, L.P. | Propietario del 10% | 17 de abril de 2018 P | — | 0 | 0 | $0 |
| Adam Zlotnick | Propietario del 10% | 10 de julio de 2014 A | — | 0 | 0 | $0 |
| David Jonathan Barrett | — | 29 de marzo de 2017 A | 19 396 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 3 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| GILEAD SCIENCES, INC. ×5 presentaciones | 27 de mayo de 2026 | 25,10% | Enmienda | — | SEC |
| Alexander Schornstein ×3 presentaciones | 24 de junio de 2024 | — | Presentación inicial | — | SEC |
| 31 de octubre de 2023 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 12 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,55% | 7 645 NS | 30 de abril de 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 9 650 NS | 31 de mayo de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| IWN · iShares Trust | — | — | 17 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 de julio de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | — | — | 20 de julio de 2026 | Diario |